Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,230 | -26,672 | -12,826 | -14,026 | -26,997 |
| Depreciation Amortization | 526 | 407 | 362 | 324 | 188 |
| Accounts receivable | 3,642 | -1,991 | -2,348 | -880 | -17 |
| Accounts payable and accrued liabilities | -348 | 53 | 107 | 391 | 66 |
| Other Working Capital | 1,944 | -2,541 | -2,082 | -7 | 2,090 |
| Other Operating Activity | -17,438 | 24,843 | 12,542 | 2,077 | 8,061 |
| Operating Cash Flow | $-16,905 | $-5,899 | $-4,245 | $-12,121 | $-16,608 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,085 | -459 | 1,000 | 0 | 1,000 |
| PPE Investments | -656 | -466 | -136 | -224 | -986 |
| Purchase Sale Intangibles | -326 | -251 | -237 | -334 | -206 |
| Other Investing Activity | -326 | -251 | -237 | -334 | -456 |
| Investing Cash Flow | $-6,067 | $-1,176 | $627 | $-558 | $-443 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 22,479 | 13,556 | 363 | 24 | 202 |
| Dividend Paid | N/A | N/A | -937 | -1,257 | -869 |
| Other Financing Activity | 12,290 | 3,510 | 4,855 | 0 | 28,868 |
| Financing Cash Flow | $34,769 | $17,065 | $4,282 | $-1,233 | $28,201 |
| Exchange Rate Effect | 157 | -35 | 0 | N/A | N/A |
| Beginning Cash Position | 10,919 | 963 | 300 | 14,212 | 3,062 |
| End Cash Position | 22,873 | 10,919 | 963 | 300 | 14,212 |
| Net Cash Flow | $11,954 | $9,955 | $663 | $-13,912 | $11,150 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,905 | -5,899 | -4,245 | -12,121 | -16,608 |
| Capital Expenditure | -656 | -466 | -136 | -224 | -988 |
| Free Cash Flow | -17,561 | -6,365 | -4,381 | -12,346 | -17,596 |